Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratko Djukanovic

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Scientific Reports|November 28, 2023
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)Ahilanandan Dushianthan, Howard W Clark, David Brealey, et al.
Journal of Asthma and Allergy|December 25, 2023
How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?Jennifer Naftel, Heena Mistry, Frances Ann Mitchell, et al.
Respiratory Research|January 8, 2021
Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthmaNazanin Zounemat Kermani, Woo-Jung Song, Yusef Badi, et al.
Allergy|June 18, 2026
Clinical Features of Cellular Senescence Pathways in Severe AsthmaWoo-Jung Song, Nazanin Zounemat Kermani, Ali Versi, et al.
Tissue Barriers|January 5, 2024
Membrane lipid composition of bronchial epithelial cells influences antiviral responses during rhinovirus infectionMadhuriben H Panchal, Emily J Swindle, Theresa J Pell, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2010
Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary diseaseBenjamin L Nicholas, Paul Skipp, Sheila Barton, et al.
American Journal of Respiratory and Critical Care Medicine|November 23, 2021
Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe AsthmaAngelica Tiotiu, Yusef Badi, Nazanin Zounemat Kermani, et al.
The European Respiratory Journal|February 10, 2017
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
Trials|December 11, 2020
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trialAhilanandan Dushianthan, Howard Clark, Jens Madsen, et al.
The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Scientific Reports|November 28, 2023
A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)Ahilanandan Dushianthan, Howard W Clark, David Brealey, et al.
Journal of Asthma and Allergy|December 25, 2023
How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?Jennifer Naftel, Heena Mistry, Frances Ann Mitchell, et al.
Respiratory Research|January 8, 2021
Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthmaNazanin Zounemat Kermani, Woo-Jung Song, Yusef Badi, et al.
Allergy|June 18, 2026
Clinical Features of Cellular Senescence Pathways in Severe AsthmaWoo-Jung Song, Nazanin Zounemat Kermani, Ali Versi, et al.
Tissue Barriers|January 5, 2024
Membrane lipid composition of bronchial epithelial cells influences antiviral responses during rhinovirus infectionMadhuriben H Panchal, Emily J Swindle, Theresa J Pell, et al.
American Journal of Respiratory and Critical Care Medicine|January 30, 2010
Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary diseaseBenjamin L Nicholas, Paul Skipp, Sheila Barton, et al.
American Journal of Respiratory and Critical Care Medicine|November 23, 2021
Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe AsthmaAngelica Tiotiu, Yusef Badi, Nazanin Zounemat Kermani, et al.
The European Respiratory Journal|February 10, 2017
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
Trials|December 11, 2020
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trialAhilanandan Dushianthan, Howard Clark, Jens Madsen, et al.
The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.
Pageof 13